ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

Prostate Cancer Prevention Trial Begins At 222 U.S. Sites

October 22, 1993

Patient Advocates; NBCC Delivers 2.6M Signatures, demands 2.6Billion

May 9, 1997

NCI, ACRIN Begin Trial Comparing Digital Mammography To Standard.

September 7, 2001

Swedish Education Says Nursing Education Should Emphasize Decision Making

December 4, 1987

In Brief: Wieand Named Director, Biostatistical Center For NSABP; LeMaistre Honored By AMA

June 30, 1995

NCI To Offer Expanded Access To Oxaliplatin

May 31, 2002